Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TUBA1B antisense RNA 1 (TUBA1B-AS1) is a **long non-coding RNA (lncRNA)** gene located on chromosome 12 and does not encode a protein[1][3][5][7]. It is transcribed antisense to the TUBA1B gene, and its transcript is classified as an lncRNA. While some lncRNAs regulate gene expression through chromatin remodeling, transcriptional interference, or mRNA stability, the specific biological roles and mechanisms of TUBA1B-AS1 have not been conclusively characterized in current literature. Some gene expression databases link TUBA1B-AS1 to differential expression in various cancers, suggesting it may have a role in human disease, especially hepatocellular carcinoma, but it is neither a classic receptor nor considered a validated therapeutic target to date[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TUBA1B antisense RNA 1 (TUBA1B-AS1).